325 Capital’s Diebold Nixdorf DBD Stock Holding History

325 Capital’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.6M	Hold	242,084	–	–	4.91%	7
2026 Q1	$18.3M	Buy	242,084 +48,683	+25%	+$3.58M	6.65%	7
2025 Q4	$13.1M	Buy	+193,401	New	+$12.1M	4.6%	9

Other funds holding DBD

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCM

Millstreet Capital Management Boston, Massachusetts $368M AUM 57.36% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

325 Capital's DBD Position: Q2 2026 in Review

325 Capital held its Diebold Nixdorf (DBD) position steady in Q2 2026 at 242,084 shares worth $20.6M. The position accounts for 4.91% of the portfolio, ranked #7.

325 Capital first reported a position in DBD in Q4 2025 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

325 Capital held 242,084 shares of Diebold Nixdorf worth $20.6M as of Q2 2026.
325 Capital left its Diebold Nixdorf share count unchanged in Q2 2026.
Diebold Nixdorf made up 4.91% of 325 Capital's portfolio in Q2 2026, its #7 holding.
325 Capital first reported a position in Diebold Nixdorf in Q4 2025 and has held it in 3 quarters since.
216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on 325 Capital's 13F filing for Q2 2026, filed 14 Aug 2026.